The present invention relates immediate release pharmaceutical suspension dosage form of Olmesartan or its pharmaceutical^ acceptable salt, hydrate or polymorph thereof comprising one or more pharmaceutical^ acceptable excipients wherein the pH of the composition is from 4- 8 and viscosity from 700-1100 cps. The invention also relates to the process for the preparation of suspension dosage form and use for the treatment of hypertension